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RESUMEN
Utilización de aislados proteicos de colza para la pro-
ducción de péptidos con actividad inhibidora de la enzi-
ma convertidora de la angiotensina (ECA).
La actividad de ECA está relacionada con una presión arte-
rial alta y enfermedades cardíacas. Un aislado proteico de colza
se hidrolizó con alcalasa para estudiar la posible presencia de
péptidos inhibidores de ECA en el hidrolizado. La hidrólisis du-
rante 30 min produjo el hidrolizado con la mayor actividad inhibi-
dora de ECA. Dos fracciones de este hidrolizado, obtenidas por
cromatografía de filtración en gel Biogel P2, se usaron para la
purificación de péptidos inhibidores de ECA. Tres fracciones con
actividad inhibidora de ECA se purificaron mediante HPLC en
fase reversa de las fracciones obtenidas mediante Biogel P2.
Esto demuestra que los hidrolizados proteicos de colza repre-
sentan una buena fuente de péptidos inhibidores de ECA.
PALABRAS-CLAVE: Aislado proteico - Colza - Enzima con-
vertidora de angiotensina - Hidrolizado proteico - Péptidos inhi-
bidores
SUMMARY
Utilisation of rapeseed protein isolates for production
of peptides with angiotensin I-converting enzyme (ACE)-
inhibitory activity. 
ACE activity is related to increased arterial pressure and
coronary diseases. A rapeseed protein isolate was hydrolyzed
with the protease Alcalase in order to investigate the possible
presence of ACE inhibitory peptides in the resulting hydrolysates.
Hydrolysis for 30 min yielded a hydrolysate with the highest ACE
inhibitory activity. Two fractions of this hydrolysate obtained by
Biogel P2 gel filtration chromatography were used for further
purification of ACE inhibitory peptides. Three fractions with ACE
inhibitory activity were purified by reverse-phase HPLC of Biogel
P2 f ract ions. This demonstrates that rapeseed protein
hydrolysates represent a good source of ACE inhibitory peptides.
KEY-WORDS: Angiotensin converting enzyme - Peptide in-
hibitors - Protein hydrolysate - Protein isolate - Rapeseed.
1. INTRODUCTION
Rapeseed is one of the most important oilseed
crops cultivated in the world, ranking fourth with
respect to oil production after soybean, palm, and
cottonseed (FAO, 2002). The main producing
countries are China, India and Canada, respectively.
Rapeseed is rich in protein (between 30 and 45%),
and therefore defatted rapeseed meal may constitute
a good source of protein for humans (Finlayson, 1976).
Protein isolates obtained from defatted rapeseed meal,
free of anti-nutritional components such as
glucosinolates, phenols or phytic acid may be used for
the fortification of foods (Dev and Mukherjee, 1986;
Zhou et al., 1990). Rapeseed protein hydrolysates
have been obtained with different proteases, such as
Alcalase, Pronase, or Neutrase (Kim et al., 1992a,b)
in order to improve the functional properties of the
original proteins (Vioque et al., 2000a). Extensive
hydrolysates to be used as food supplements or in
special medical diets have been obtained as well
(Vioque et al., 1999). 
In recent years, protein hydrolysates are also
considered a source of bioactive peptides. These are
short-chain peptides, produced by enzymatic
hydrolysis, that can be absorbed by intestinal
enterocytes and reach the blood stream leading to a
biological activity that may be beneficial (Vioque et
al., 2000b). Bioactive peptides with different activities
have been described, including immunomodulatory,
antimicrobial, antithrombotic and antihypertensive
activities (Clare and Swaisgood, 2000).
Antihypertensive peptides inhibit the
angiotensin-converting enzyme (ACE). This enzyme
hydrolyzes the decapeptide angiotensin I to yield the
vasoconstrictor octapeptide angiotensin II, and in
addition hydrolyzes the vasodilator peptide
bradikinin. Angiotensin II is involved in the release of
aldosterone, a sodium-retaining steroid, which
increases blood pressure. Thus, the activity of ACE
increases blood pressure by raising vascular
resistance and fluid volume. High blood pressure is
associated with a higher risk of cardiovascular
disease and stroke. ACE inhibitors are used in the
treatment of hypertension and have been studied for
the treatment of chronic heart failure and myocardial
infarction (Pitt, 1997).
ACE peptide inhibitors have been purified from
several foodstuffs: casein, whey, cheese, gelatine,
fish, wheat, corn, chickpea or even mushrooms
(Yamamoto, 1997). Alcalase has been used for the
preparation of ACE peptide inhibitors from protein of
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different sources, such as bovine proteins (Hyun and
Shin, 2000; Kim et al., 2001), fish (Byun and Kim,
2001; Matsufuji et al., 1993; 1994), wheat (Matsui et
al., 1999; 2000), soy (Wu and Ding, 2002), and
chickpea (Pedroche et al., 2002) proteins.
The goal of this paper was to determine their
presence and to purify ACE-inhibitory peptides in
defatted rapeseed meal protein hydrolysates
produced by treatment with the protease Alcalase.
2. MATERIALS AND METHODS
Materials
Hippuryl-L-histidyl-L-leucine (HHL), Captopril, 2,4,6-
trichloro-s-triazine (TT), trinitrobenzenesulphonic
acid (TNBS) and phenylmethylsulfonyl fluoride
(PMSF) were purchased from Sigma. All other
chemicals were of analytical grade.
Rapeseed seeds were a gift from Koipesol
Semillas S.A. (Sevilla, Spain). The seeds were
ground and extracted with hexane in a soxhlet
extractor for 9 h to remove most of the fat. The
resulting defatted rapeseed flour was used as the
starting material for the production of protein
hydrolysates.
Proteolytic enzymes
The enzyme used was Alcalase 2.4 L (Novo
Nordisk, Bagsvaerd, Denmark). Alcalase 2.4 L is a
microbial protease preparation with endopeptidase
activity produced by Bacillus licheniformis. A main
component of the commercial preparation is the
serine protease subtilisin A. The specific activity of
Alcalase 2.4 L is 2.4 Anson Unit (AU)/g.
Protein determination
Protein amounts were determined by elemental
analysis using a LECO CHNS-932 analyzer (St.
Joseph, MI), and were calculated as percentage
nitrogen content x 6.25.
Preparation of angiotensin-converting enzyme
Angiotensin-converting enzyme was prepared
according to Hayakari et al. (1978) with
modifications. Pig lungs purchased in a local market
were used as starting material. Tissue samples were
diced and homogenized in 10 volumes of ice-cold 10
mM potassium phosphate buffer, pH 8.3, containing
0.25 M sucrose and 0.1 mM PMSF. The homogenate
was centrifuged at 5000 g for 10 minutes, and the
resulting supernatant was dialyzed for 24 hours
against 20 volumes of the same buffer at 4 oC. The
buffer was renewed four times. The dialyzed was
used as the source of ACE. In order to verify the
absence of undesirable proteases such as
carboxypeptidase in ACE extracts, the kinetics of
HHL hydrolysis by ACE was followed in the presence
or absence of captopril, a potent ACE inhibitor. This
assay demonstrated that hydrolysis was due to ACE
and not to other proteases, since hydrolysis of HHL
in the presence of captopril was residual and similar
to the hydrolysis of the substrate alone (data not
shown).
Assay of angiotensin-converting enzyme
Angiotensin-converting enzyme activity was
determined according to Hayakari et al. (1978) with
modifications. This method relies on the colorimetric
reaction of hippuric acid with TT, developed in a 0.5
ml incubation mixture containing a 40 µmol
potassium phosphate buffer, pH 8.3, 300 µmol
sodium chloride, 1.5 µmol of HHL, and 1 µg of
enzyme extract. Incubation was carried out for 15
minutes at 37 oC. The reaction was terminated by the
addition of 1.5 ml 3% TT in dioxane, followed by 3 ml
of 0.2 M phosphate buffer, pH 8.3. After the reaction
mixtures were centrifuged at 10000 g for 10 min, the
product of the reaction was determined in the
supernatant by measuring its absorbance at 382 nm.
Preparation of protein isolate
Defatted rapeseed flour (20 g) was suspended in
200 ml of 0.2% NaOH solution, pH 12, and extracted
by stirring for 1 hour. After centrifugation at 8000 g for
20 min, two additional extractions of the pellet were
carried out with half the volume of alkaline solution.
The three supernatants were pooled and the pH
adjusted to the isoelectric point (pH 4.3) and the
precipitate formed was recovered by centrifugation
as described above. The precipitate was washed
with distilled water adjusted to pH 4.3 and
freeze-dried until further use.
Hydrolysis
Protein isolates were hydrolyzed in batches by
treatment with Alcalase in a pH-stat for 60 minutes.
The protein isolate was suspended in water and the
pH adjusted to 8. A hydrolysis curve was obtained by
the pH-stat technique using the following hydrolysis
parameters: substrate concentration, 10%; enzyme/
substrate ratio, 0.3 AU/g, pH 8, and temperature 50
oC. Hydrolysis was conducted in a 1000 ml reaction
vessel equipped with a stirrer, thermometer and pH
electrode. Aliquots (50 ml) were withdrawn at 10 min,
30 min and 60 min. Hydrolysis was stopped by
acidification to pH 5. Hydrolysates were clarified by
ultrafiltration through 0.45 nm filters to remove
insoluble substrate and residual enzymes. Filtrates
were lyophilized for storage at –20 oC.
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Degree of hydrolysis
The degree of hydrolysis was calculated by the
determination of free amino groups by reaction with
TNBS (Adler-Nissen, 1979). The total number of
amino groups was determined in a sample 100%
hydrolyzed by incubation with 6N HCl at 120 oC for
24 hours.
Biogel P2 chromatography
Rapeseed protein hydrolysates (10 mg in 50 mM
ammonium bicarbonate) were injected into a Biogel
P2 (BIO-RAD) gel filtration column (2 x 55 cm) at a
flow rate of 10 ml/h, 50 mM ammonium bicarbonate.
Fractions selected for further purification of peptides
were pooled and taken to dryness before HPLC C18
chromatography. Peptide molecular masses were
determined using cytochrome C (12384 Da),
bacitracin (1400 Da), Val4-angiotensin (917 Da),
Arg-Lys-Glu-Val-Tyr (693 Da) and Trp-Gly (261 Da)
as molecular weight standards.
HPLC C18 chromatography
Fractions collected from Biogel P2
chromatography were re-dissolved in water and
injected in an HPLC reverse-phase column (C18
Hi-Pore RP-318, 250 x 10 BIO-RAD column). Elution
was achieved through a linear gradient of acetonitrile
(0 to 30% for 60 min) containing 0.1% trifluoroacetic
acid at a flow rate of 4 ml/min at 30 oC. Elution was
monitored at 214 nm and individual peaks were
collected for (assay) trials of ACE inhibitory activity.
3. RESULTS AND DISCUSSION
In general, ACE inhibitory peptides have been
obtained from food proteins by hydrolysis using
digestive enzymes, such as pepsin, pancreatin,
trypsin or chymotripsin. More recently, microbial
enzymes such as Alcalase (see Introduction) or
flavourzyme (Pedroche et al., 2002; Janitha et al.,
2002) have been employed in the generation of
antihypertensive peptides.
A rapeseed protein isolate obtained from defatted
rapeseed meal by alkaline extraction and isoelectric
precipitation was used as a substrate for the
generation of the protein hydrolysate. This protein
isolate, with more than 95% protein content, is a
good starting material for hydrolysis. Alcalase is a
non-specific commercial endoprotease preparation
that has been used in our laboratory for the
preparation of extensive protein hydrolysates from
rapeseed (Vioque et al., 1999), sunflower (Villanueva
et al., 1999) and chickpea (Clemente et al., 1999).
These previous studies showed that treatment with
Alcalase for less than 30 minutes is usually enough
to reach the maximum degree of hydrolysis. The
rapeseed isolates used for the present work were
hydrolyzed for up to 1 hour (Figure 1). The original
isolate already presented an ACE inhibitory activity
of 23%, which was approximately doubled by the
proteolytic treatment. The degree of hydrolysis hardly
increased after 10 minutes of treatment with
Alcalase, although ACE inhibitory activity kept
increasing after that time. This most likely highlights
the fact that after a certain point, the hydrolysis of
relatively few peptidic bonds may be critical for the
generation of bioactive peptides.
Since treatment with Alcalase for more than 30
minutes did not substantially increase the ACE
inhibitory activity, which is consistent with previous
work in which the maximum inhibition of ACE was
achieved after 30 minutes of hydrolysis of chickpea
proteins (Pedroche et al., 2002), the hydrolysate
obtained after 30 minutes of hydrolysis was used in
attempt to purify the ACE inhibitory peptides. 
After centrifugation and filtration through 0.45
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Figure 1
Time course of the hydrolysis of rapeseed protein isolate
by Alcalase and ACE inhibitory activity of the resulting
hydrolysates (data corresponding to duplicate determinations
and the corresponding average are shown).
Figure 2
Biogel P2 gel filtration chromatography of 30 minutes
rapeseed protein hydrolysate and ACE inhibitory activity
of the fractions collected (data corresponding to duplicate
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to a Biogel P2 gel filtration column (Figure 2).
Fractions 6 to 20 were tested for ACE inhibitory
activity. Fractions 12 and 13, corresponding to a
shoulder in the protein elution profile, gave the
highest ACE inhibition, and were selected for further
purification of peptide inhibitors. These fractions have
an elution volume that corresponds to 1500 Da
apparent molecular weight. This would correspond to
peptides with 12-13 residues as an average.
Although this size is higher than the usual size
reported for ACE inhibitory peptides, peptides of this
size possessing ACE inhibitory activity have been
purified from casein (Maruyama and Suzuki, 1982). 
Pooled fractions 12 and 13 selected from the
Biogel P2 column were loaded on a HPLC C18
reverse phase column for further purification of
peptides. The elution profile is shown in Figure 3.
Peptides were collected in four fractions and tested
for ACE-inhibitory activity (Figure 4). Peptides
belonging to the fraction with the longest retention
time, between 37.5 and 49 min, possessed the
highest inhibitory activity. This was an expected
result, since ACE inhibitory peptides are usually
constituted by hydrophobic amino acids that
increase the interaction of peptides with the column
and delay elution. A similar pattern has also been
observed during the purification of chickpea ACE
inhibitory peptides (Pedroche et al., 2002).
Individual peaks collected from this fraction were
tested for ACE inhibitory activity (Figure 5). Three
peaks were inhibitory for ACE, demonstrating the
generation of ACE inhibitory peptides after rapeseed
protein isolate hydrolysis. Therefore, rapeseed
proteins may represent a source of bioactive
peptides after modification by food-grade microbial
enzymes. It remains to be determined whether these
peptides are resistant to hydrolysis by digestive
enzymes, and whether they can be absorbed by
enterocytes and be incorporated into the
bloodstream.
These results point out the possibility of obtaining
bioactive peptides from rapeseed proteins by means
of a controlled protein hydrolysis using a microbial
protease, allowing the generation of a functional food
product with possible applications in specific diets.
The low cost of the protease and substrate represent
the revalorization of an agricultural waste, defatted
rapeseed meal that may be transformed into a highly
valuable additive (added value) such as hypotensive
protein hydrolysates.
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